Selective action of the iminosugar isofagomine, a pharmacological chaperone for mutant forms of acid-β-glucosidase
- 15 December 2006
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 73 (9) , 1376-1383
- https://doi.org/10.1016/j.bcp.2006.12.015
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanismsProceedings of the National Academy of Sciences, 2006
- Substrate reduction therapy of glycosphingolipid storage disordersJournal of Inherited Metabolic Disease, 2006
- An open-label, noncomparative study of miglustat in type I Gaucher disease: Efficacy and tolerability over 24 months of treatmentClinical Therapeutics, 2005
- Astrocyte glycogen metabolism is required for neural activity during aglycemia or intense stimulation in mouse white matterJournal of Neuroscience Research, 2004
- N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Evaluation of Isofagomine and Its Derivatives As Potent Glycosidase InhibitorsBiochemistry, 1996
- Congenital Sucrase-Isomaltase DeficiencyJournal of Pediatric Gastroenterology and Nutrition, 1995
- A rapid and simple assay method for UDP-glucose: ceramide glucosyltransferaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1992
- Sucrase-isomaltase deficiency in humans. Different mutations disrupt intracellular transport, processing, and function of an intestinal brush border enzyme.Journal of Clinical Investigation, 1988
- INHIBITORS OF THE BIOSYNTHESIS AND PROCESSING OF N-LINKED OLIGOSACCHARIDE CHAINSAnnual Review of Biochemistry, 1987